The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Background: The prevalence of type 2 diabetes is on the increase worldwide, and it represents about 90% of adults who are diagnosed with diabetes. Overweight and obesity, lifestyle, genetic predisposition and gut microbiota dysbiosis have been implicated as possible risk factors in the development of type 2 diabetes. In particular, low intake of dietary fibre and consumption of foods high in fat and sugar, which are common in western lifestyle, have been reported to contribute to the depletion of specific bacterial taxa. Therefore, it is possible that intake of high dietary fibre may alter the environment in the gut and provide the needed substrate for microbial bloom. Aim: The current review is a systematic review and meta-analysis which evaluated the role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes. Methods: This is a systematic review and meta-analysis of randomised controlled trials which relied on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework. Electronic searches were conducted using EBSCOHost with links to Health Sciences Research Databases, EMBASE and Google Scholar. The reference lists of articles were also searched for relevant studies. Searches were conducted from date of commencement of the database to 5 August 2020. The search strategy was based on the Population, Intervention, Comparator, Outcomes, Studies (PICOS) framework and involved the use of synonyms and medical subject headings (MesH). Search terms were combined with Boolean operators (OR/AND). Results: Nine studies which met the inclusion criteria were selected for the systematic review and meta-analysis, and four distinct areas were identified: the effect of dietary fibre on gut microbiota; the role of dietary fibre on short-chain fatty acids (SCFAs); glycaemic control; and adverse events. There was significant difference (p < 0.01) in the relative abundance of Bifidobacterium with a mean difference of 0.72 (95% CI, 0.56, 0.89) between the dietary fibre group compared with placebo. In relation to the meta-analysis for SCFAs, while there was significant difference (p = 0.02) between the dietary fibre group and placebo with a standardised mean difference of 0.5 (95% CI, 0.08, 0.91) regarding total SCFAs, the differences were not significant (p > 0.05) in relation to acetic acid, propionic acid and butyric acid. There was only significant improvement (p = 0.002) with respect to glycated haemoglobin with a mean difference of −0.18 (95% CI, −0.29, −0.06) between the dietary fibre group and placebo group. Differences between the two groups were not significant (p > 0.05) in relation to fasting blood glucose and homeostatic model assessment of insulin resistance (HOMA-IR). Furthermore, there were no significant differences between the two groups in subjects who reported adverse events. It is possible that the promotion of SCFA producers in greater diversity and abundance by dietary fibre in this review led to improvement in glycated haemoglobin, partly due to increased glucagon-like peptide-1 (GLP-1) production. In addition, Bifidobacterium lactis has been reported to increase glycogen synthesis, decrease expression of hepatic gluconeogenesis genes, improve translocation of glucose transport-4 and promote glucose uptake. It is also possible that the reduction in body weight of participants in the intervention group compared with control may have contributed to the observed improvement in glycated haemoglobin. Conclusion: This systematic review and meta-analysis have demonstrated that dietary fibre can significantly improve (p < 0.05) the relative abundance of Bifidobacterium, total SCFAs and glycated haemoglobin. However, dietary fibre did not appear to have significant effect (p > 0.05) on fasting blood glucose, HOMA-IR, acetic acid, propionic acid, butyric acid and adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A ran-domized double-blind trial in healthy adults demonstrated that pectin-containing soluble fiber improved postprandial glycemic control likely via increased GLP-1 secretion [129]”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [129]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Methley, A. M., Campbell, S., Chew-Graham, C., McNally, R., & Cheraghi-Sohi, S. (2014) · BMC Health Services Research · doi:10.1186/s12913-014-0579-0 · Cited by 2,706
The impact of dietary fiber on gut microbiota in host health and disease
Makki, K., Deehan, E. C., Walter, J., & Bäckhed, F. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.012 · Cited by 2,517 · cited 8×
“[7], dietary fibre can be subdivided into polysaccharides (NSP), resistant starch, and resistant oligosaccharides.”
BackgroundInfluentialGut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., et al. (2018) · Science · doi:10.1126/science.aao5774 · Cited by 2,304 · cited 3×
“[13], the acetate-producing Bifidobacterium pseudocatenulatum was one of the most significantly promoted SCFA producers, and the enhancement of these positive responders reduced the producers of compounds, such as indole and hydrogen sulphide, which could be metabolically detrimental.”
BackgroundResultSelf-citationWing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Role of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
(2017) · doi:10.1038/s41467-017-01973-8 · Cited by 986 · cited 1×
“However, our current understanding of the exact relationships between the human gut microbiome and disease remains limited [12].”
Background
Research works printed but not linked: 1
- The Nordic Cochrane Centre (2014). Review Manager (RevMan) [Computer Program], The Nordic Cochrane Centre, The Cochrane Collaboration. Version 5.3.
Cited by
Items 101–138 of 138
Liu, T., Liu, B., Jiang, Y., Ojo, O., Jiang, X.-S., Wang, Y., Wang, C., & Wang, C. (2024) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2024.103673 · Cited by 3
Self-citationDysbiosis and Regulation of Gut Microbiota in Type 2 Diabetes Mellitus
Minakshi, Kumari, H., Prakash, S., & Kumar, A. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010318580240910061534 · Cited by 5
Kim, N. V., Zotov, V. A., Alekseev, V. A., & Sa, S. (2023) · Voprosy Pitaniya · doi:10.33029/0042-8833-2023-92-2-18-25 · Cited by 5
El-Deyarbi, M., Ahmed, L. A., King, J., Adi, Z. S., Juboori, A. A., Mansour, N. A., Nuaimi, H. A., Beiram, R., & Aburuz, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327211 · Cited by 4
“…electrolyte panel monitoring [11], low-glycaemic index diets with high fiber content to improve glycated haemoglobin A1c (HbA1c) levels in patients with T2DM [12–13], pharmacist-led medication therapy management (MTM) [14], and the use of telemedicine technology through mobile applications [15].”
Zainab, A., Mago, A., Mehmood, A., Riad, M., & Sonavane, S. R. (2022) · National Journal of Health Sciences · doi:10.21089/njhs.62.0075 · Cited by 2
Khodaie, S.-A., Razavi, R., Nikkhah, H., Namiranian, N., & Kamalinejad, M. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01528-6 · Cited by 2
“Besides, evidence points to the improvement of the glycemic profile in diabetic patients (reduction of FBS, HbA1c, and insulin resistance) following a high dietary fiber intake (Ojo et al. 2020).”
Short-chain fatty acids and their impact on human health – a review
Czachajda, M., Góral, A., Duszyńska, K., Dolepski, K., Żuk, K., & Firlej, E. (2024) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/190750 · Cited by 3
“Whether SCFA will find use as components in conventional therapies depends on a better understanding of them; therefore, it is still important to carry out studies that focus primarily on their points of entry.”
BackgroundMitigating Diabetic Foot Ulcers: The Effect of Diet and Microbiome
Coon, S. D. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106629 · Cited by 2
Non-Insulin Therapeutic Option in Management of Diabetes: Life Style Modification; Diet and Exercise
Kabadi, U. M. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115023 · Cited by 1
“Most diabetic diets also recommend adequate fiber intake to delay food absorption and induce favorable alterations in gut morphology [17]-[27].”
BackgroundImpacto do desequilíbrio da microbiota intestinal no desenvolvimento da obesidade
Goulart, A. L. G., Costa, E. M. D. A., Bacelar, M. G. L., Nascimento, S. S., & Gomes, T. F. (2023) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.rmrp.2023.204198 · Cited by 5
Piłot, M., Dzięgielewska-Gęsiak, S., Wolińska-Grabowska, A., & Muc‐Wierzgoń, M. (2024) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/175109 · Cited by 1
“…consumption, as is the case with this married couple, reduces bacteria diversity in the gut but also reduces production short-chain fatty acids (SCFA) and a shift towards the utilization of less favorable substrates, such as dietary and endogenous protein sources, by the gut microbiota [42,43].”
BackgroundNutrient quality in dietary therapy for diabetes and diabetic kidney disease
Tsuruta, H., Sugahara, S., & Kume, S. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14208 · Cited by 1
“According to a meta-analysis focusing on individuals with type 2 diabetes, a signi fi cant reduction in HbA1c and fasting blood glucose levels was reported with high dietary fi ber intake over 3 – 12 weeks 34,35 .”
MethodZulfiqar, A. (2023) · Journal of Islamic International Medical College · doi:10.57234/jiimc.june23.1738 · Cited by 3
Alzahrani, Q. E., & Pinto, L. H. (2021) · Natural Resources for Human Health · doi:10.53365/nrfhh/142486
Maldini, A. C., Calvo, M. L., Schlinder, A., HEREDIA, V. V. O., Marco, R. D., Forlin, G. M. E., González, J. P., Apoloni, S. B., Burgos, M. A., López, C. E., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v57i1.680
Ramires, E. H. D. S., Messias, M. V. M., Santos, W. D. C. S., da Cruz, A. B. G., & Moreira, H. N. S. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n3-217
Mandal, S., Kuriakose, S., & Shridhar, K. (2024) · Frontiers in Environmental Health · doi:10.3389/fenvh.2024.1339674
Ramírez, L. N. W., Mereles, L. G., Coronel, E., Caballero, S., & Piris, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21873-6.00026-9
Abdulhasan, R. S. (2024) · European journal of ecology, biology and agriculture. · doi:10.59324/ejeba.2024.1(5).05
Steffen, B. T., Lusczek, E. R., Jacobs, D. R., Chen, C., Murthy, V. L., Horn, L. V., Terry, J. G., Carr, J. J., & Steffen, L. M. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70138
Kuramoto, N., Hironaka, J., Okada, H., Hasegawa, Y., Nakajima, H., Okamura, T., Nakatani, R., Majima, S., Ushigome, E., Nakanishi, N., et al. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.08.005
Wang, J., Zhou, J., He, Y., Huang, S., Li, H., Cao, J., & Ye, J. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01252-z
“Meta-analyses of randomized controlled trials further confirm that fiber mitigates gut microbiota dysbiosis, thereby inhibiting progression from diabetes to DKD [46].”
Song, C.-Y., Yang, Y., & Hong, K. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103487
Donatini, D., & Blaye, L. (2025) · Medical Research Archives · doi:10.18103/mra.v14i3.7384
Dou, M., Xu, J., Ye, X., Liu, J., & Shi, L. (2026) · International Journal of Endocrinology · doi:10.1155/ije/8852077
“Another study showed that Bifdobacteria increased hepatic glycogen synthesis, decreased the expression of hepatic gluconeogenesis genes, improved the translocation of glucose transporter 4 (GLUT4), and promoted glucose uptake [17].”
Kowalczyk, A., Fąfara, M., Jeczkało, M., Kosiorowska, M., Lasoń, J., Makulska, M., Płachta, W., Sęk, W., Sieradzka, A., & Wegenko, C. M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5787
Jaafari, Z., Hassanzadeh, J., Sayadi, M., Sharifi, M. H., & Mirahmadizadeh, A. (2026) · Health Science Reports · doi:10.1002/hsr2.72569 · Cited by 1
“Therefore, while individual‐level clinical studies have consistently linked adequate fiber intake with lower diabetes risk specifically through mechanisms such as modulating gut microbiota dysbiosis [42], our macro‐level findings should be interpreted with caution.”
Elouafy, Y., Balahbib, A., Fessikh, M. E., Gharby, S., Omari, N. E., Abdulmonem, W. A., Zengin, G., & Bouyahya, A. (2026) · eFood · doi:10.1002/efd2.70162
Dietary Polysaccharides and the Regulation of Blood Glucose and Lipid Parameters—A Narrative Review
Ojo, O., Onilude, Y., Ojo, O. O., Apau, V., Kazangarare, I., Agyapong, D., Brooke, J. M., & Wang, X. (2026) · Nutrients · doi:10.3390/nu18132143
“This disruption Dietary polysaccharides have been reported to ameliorate glucose dysregulation by modulating gut microbiota dysbiosis, promoting eubiosis and generating advantageous metabolites [2–4].”
Self-citationGut microbiome and diabetes: Emerging perspectives in metabolic regulation
Kaur, N., Kaur, N., Verma, A., & Sharma, R. K. (2026) · Scripta Medica · doi:10.5937/scriptamed57-61236
“108 According to a consistent study, almond supplements can lower body weight index and red blood pigment in individuals with T2DM while increasing microbes that produce short-chain fatty acids.”
Sodré, A. F. P., Rodrigues, L. G., Sloan, K. P., Sloan, L. A., Tanaka, M., Curi, R., Takeda, L. N., Goulart, R. D. Á., de Souza, A. L. D. M., Detregiachi, C. R. P., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156554
“Additionally, they can be absorbed and enter the peripheral circulation via the portal system, thereby ensuring systemic effects [203].”
Frigo, F. F., Fasching, P., & Brath, H. (2026) · Nutrients · doi:10.3390/nu18162672 · Cited by 1
“This shift in microbial diversity and functional capacity contributes to improved glucose homeostasis, enhanced insulin sensitivity, and reduced low-grade systemic inflammation [71–74].”
Kilci, Z., Çetin, R. Ü., Çetin, D. Ç., Bayizit, A. A., & Sogut, B. (2026) · Food Science and Technology International · doi:10.1177/10820132261471724
Role of gut microbiota in the development of obesity and metabolic disorders: literature review
Постоева, А. В., Leontyeva, A. G., Малыгина, О. Г., Александровна, П. Н., & Dvoryashina, I. V. (2026) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2026-15-2-34-44
Farisi, Q. A., Tanjung, A. E., & Ulhaq, Z. (2026) · Eduvest - Journal Of Universal Studies · doi:10.59188/eduvest.v6i9.53339
“Type 2 diabetes mellitus (T2DM) has emerged as one of the most pressing global health challenges of the modern era, accounting for approximately 90% of all diabetes cases among adults (Ojo et al., 2020a).”
Chung, S., Kim, J., 남영도, & Lim, M. Y. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113626
Zhou, Z., Fang, Y., Luo, M., Du, H., Guo, X., Chen, Y., Han, Y., & Xiao, H. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c07831
Metadata
- Authors
- Ojo, O., Feng, Q.-Q., Ojo, O. O., & Wang, X.-H.
- Affiliations
- South London and Maudsley NHS Foundation Trust (GB)
- The School of Nursing, Soochow University, Suzhou 215006, China
- Soochow University (CN)
- Corresponding author
- Ojo, Omorogieva
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-10-23
- Volume
- 12
- Issue
- 11
- Pages
- 3239
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7690692
- OpenAlex
- W3093727803
- Cited by
- 134
- References
- 47
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 30 · 2023: 25 · 2022: 22 · 2021: 15 · 2020: 2
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greenwich Academic Literature Archive (University of Greenwich) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- dietary fiber, type 2 diabetes, gut dysbiosis, short-chain fatty acids, Bifidobacterium, glycemic control, HbA1c, fasting blood glucose, adverse events, probiotics, prebiotics, dietary intervention, gut microbiota modulation, acetic acid, propionic acid, butyrate, fecal microbiota transplantation
- MeSH terms
- Gastrointestinal Microbiome, Glycemic Control, Adult, Diabetes Mellitus, Type 2, Dietary Fiber, Fatty Acids, Volatile, Female, Glycated Hemoglobin, Humans, Male, Randomized Controlled Trials as Topic, Glucagon-Like Peptide 1, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.